Ferring Pharmaceuticals

Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments in the areas of Gastroenterology, Reproductive Health, Urology/Oncology, Endocrinology and Orthopaedics. Ferring headquarters operates from Saint-Prex, Switzerland and its products are available in 110 countries. http://www.ferring.com/en/about-ferring/ (link to Ferring Corporate video)

In Australia, Ferring Pharmaceuticals markets PENTASA® (mesalazine) and CORTIMENT® (oral budesonide) indicated for the treatment of Inflammatory Bowel Disease (IBD), PICOSALAX® (sodium picosulfate/magnisium citrate), KLYX® (docusate sodium/sorbitol), Fleet® enema and Phosphosoda® (sodium phosphate monobasic & dibasic) for bowel cleansing, and GLYPRESSIN® Solution (terlipressin) indicated for the treatment of bleeding oesophageal varices (BOV) and hepatorenal syndrome (HRS).

Ferring is a proud Gold Sponsor of GESA AGW 2017. Please visit us at stand 39.

Ferring Pharmaceuticals Pty Ltd
Suite 2, Level 1, Building 1, 
20 Bridge Street
Pymble NSW 2073

Tel: 61 2 9497 2300
Fax: 61 2 9497 2399
Email: enquiries@ferring.com
Free phone: 1800 33 77 46
Website: www.ferring.com.au

 

 

  Stand/Booth No. 39